You are here

December 10, 2019

AdvaMed Welcomes Progress On U.S.-Mexico-Canada Agreement

Washington, D.C. – The Advanced Medical Technology Association (AdvaMed) today issued the following statement from President and CEO Scott Whitaker on the newly upgraded United States-Mexico-Canada Agreement (USMCA):

“The USMCA represents a significant step forward in terms of transparency, regulatory fairness and ensuring open access to markets across all three countries, fostering greater patient access to the latest medical technology innovations and further regulatory harmonization.

“The broad bipartisan support announced today for the newly upgraded USMCA should clear the way for congressional passage by year-end, as well as final approvals by the governments of Mexico and Canada. We commend U.S. Trade Representative Robert Lighthizer, the Trump administration, leaders in Congress and our trading partners in Canada and Mexico for their hard work in bringing us to this point.  

“We urge the U.S. Congress and the governments of Mexico and Canada to proceed with final approvals and ratify this agreement as expeditiously as possible.”